Detalles de la búsqueda
1.
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group.
Int J Gynecol Cancer
; 32(6): 753-760, 2022 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35063943
2.
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer.
Breast Cancer Res Treat
; 187(1): 155-165, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33591468
3.
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Br J Cancer
; 122(7): 1119, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31949268
4.
Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer.
Breast Cancer Res Treat
; 181(1): 97-105, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32240454
5.
Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Br J Cancer
; 120(10): 959-967, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30967649
6.
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 19(1): 127-138, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29158011
7.
Effect of lipegfilgrastim administration as prophylaxis of chemotherapy-induced neutropenia on dose modification and incidence of neutropenic events: real-world evidence from a non-interventional study in Belgium and Luxembourg.
Acta Clin Belg
; 76(1): 10-15, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31399016
8.
Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial.
Clin Cancer Res
; 27(2): 504-512, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33082214
9.
Interest for a Systematic Rehabilitation Program Including Physical Exercise and Lifestyle Accompaniment for Women Recently Treated for Early Breast Cancer: A Comparative Study.
Anticancer Res
; 40(8): 4253-4261, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32727752
10.
Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor-Positive Metastatic Breast Cancer.
Clin Cancer Res
; 22(24): 6002-6009, 2016 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27267854
11.
Dietetic and Psychological Mindfulness Workshops for the Management of Cachectic Cancer Patients. A Randomized Study.
Anticancer Res
; 35(11): 6311-5, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26504068
12.
Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma.
Lung Cancer
; 88(1): 63-9, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25682316
13.
Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.
J Clin Oncol
; 31(20): 2586-92, 2013 07 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23733761
Resultados
1 -
13
de 13
1
Próxima >
>>